Joaquin Duato said finding a cure for certain cancers and turning others into chronic diseases is an achievable target for the coming decade. on.wsj.com/4oj8JNm
Joaquin Duato said AI was already helping the company develop medicines faster, but the extent to which it boosts its bottom line has yet to be seen.
